Innospec Stock Forecast, Price & News

Innospec (NASDAQ:IOSP) Frequently Asked Questions

Is Innospec a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Innospec stock.
View analyst ratings for Innospec or view top-rated stocks.

How has Innospec's stock price been impacted by COVID-19?

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IOSP stock has increased by 16.0% and is now trading at $84.03.
View which stocks have been most impacted by COVID-19.

Are investors shorting Innospec?

Innospec saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 182,600 shares, a decline of 52.8% from the October 31st total of 387,000 shares. Based on an average daily volume of 105,900 shares, the short-interest ratio is presently 1.7 days. Approximately 0.8% of the shares of the stock are sold short.
View Innospec's Short Interest.

When is Innospec's next earnings date?

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for Innospec.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) released its earnings results on Tuesday, November, 2nd. The specialty chemicals company reported $1.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.13 by $0.02. The specialty chemicals company had revenue of $376.10 million for the quarter, compared to the consensus estimate of $358.50 million. Innospec had a trailing twelve-month return on equity of 12.31% and a net margin of 6.65%. During the same quarter in the previous year, the business posted $0.71 EPS.
View Innospec's earnings history.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, November 2nd. Shareholders of record on Tuesday, November 16th will be paid a dividend of $0.59 per share on Wednesday, November 24th. This represents a dividend yield of 1.3%. The ex-dividend date is Monday, November 15th. This is an increase from Innospec's previous Semi-Annual dividend of $0.57.
View Innospec's dividend history.

Is Innospec a good dividend stock?

Innospec pays an annual dividend of $1.18 per share and currently has a dividend yield of 1.44%. Innospec does not yet have a strong track record of dividend growth. The dividend payout ratio of Innospec is 31.98%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Innospec will have a dividend payout ratio of 22.91% next year. This indicates that Innospec will be able to sustain or increase its dividend.
View Innospec's dividend history.

What price target have analysts set for IOSP?

1 analysts have issued 1-year price objectives for Innospec's shares. Their forecasts range from $110.00 to $110.00. On average, they expect Innospec's share price to reach $110.00 in the next year. This suggests a possible upside of 30.9% from the stock's current price.
View analysts' price targets for Innospec or view top-rated stocks among Wall Street analysts.

Who are Innospec's key executives?

Innospec's management team includes the following people:

• Patrick S. Williams, President, Chief Executive Officer & Director (LinkedIn Profile)
• Phil Boon, Chief Operating Officer & Executive Vice President
• Ian Philip Cleminson, Chief Financial Officer & Executive Vice President
• Ian Malcolm McRobbie, Chief Technology Officer & Senior Vice President
• David B. Jones, Secretary, Chief Compliance Officer & VP

What is Patrick S. Williams' approval rating as Innospec's CEO?

12 employees have rated Innospec CEO Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among Innospec's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Innospec's key competitors?

Some companies that are related to Innospec include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Albemarle (ALB), Celanese (CE), RPM International (RPM), Ashland Global (ASH), Balchem (BCPC), Quaker Chemical (KWR), Sensient Technologies (SXT), H.B. Fuller (FUL), NewMarket (NEU), Stepan (SCL), Valaris (VAL) and Minerals Technologies (MTX).
View all of IOSP's competitors.

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.81%), Dimensional Fund Advisors LP (4.73%), Alliancebernstein L.P. (3.95%), Janus Henderson Group PLC (3.67%), Wasatch Advisors Inc. (2.26%) and Geode Capital Management LLC (1.82%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Milton C Blackmore and Patrick Williams.
View institutional ownership trends for Innospec.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, BlackRock Inc., Invesco Ltd., Eagle Asset Management Inc., Renaissance Technologies LLC, Tygh Capital Management Inc., Dimensional Fund Advisors LP, and UBS Group AG. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Ian Cleminson, Milton C Blackmore, and Patrick Williams.
View insider buying and selling activity for Innospec or view top insider-selling stocks.

Which institutional investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Alliancebernstein L.P., Goldman Sachs Group Inc., Millennium Management LLC, Janus Henderson Group PLC, Morgan Stanley, Two Sigma Advisers LP, and Two Sigma Investments LP.
View insider buying and selling activity for Innospec or or view top insider-buying stocks.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $84.03.

How much money does Innospec make?

Innospec has a market capitalization of $2.07 billion and generates $1.19 billion in revenue each year. The specialty chemicals company earns $28.70 million in net income (profit) each year or $3.69 on an earnings per share basis.

How many employees does Innospec have?

Innospec employs 1,900 workers across the globe.

When was Innospec founded?

Innospec was founded in 1938.

What is Innospec's official website?

The official website for Innospec is www.innospecinc.com.

Where are Innospec's headquarters?

Innospec is headquartered at 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at (303) 792-5554, via email at [email protected], or via fax at 303-792-5668.